Patents by Inventor Greg Duke

Greg Duke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9994550
    Abstract: Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: June 12, 2018
    Assignee: 3-V Biosciences, Inc.
    Inventors: Allan S. Wagman, Russell J. Johnson, Cristiana A. Zaharia, Haiying Cai, Lily W. Hu, Greg Duke, Yamini Ohol-Gupta, Timothy Heuer, Marie O'Farrell
  • Publication number: 20160326141
    Abstract: Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds.
    Type: Application
    Filed: January 7, 2015
    Publication date: November 10, 2016
    Inventors: Allan S. Wagman, Russell J. Johnson, Cristiana A. Zaharia, Haiying Cai, Lily W. Hu, Greg Duke, Yamini Ohol, Timothy Heuer, Marie O'Farrell
  • Publication number: 20140220075
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Application
    Filed: March 21, 2014
    Publication date: August 7, 2014
    Applicant: MEDIMMUNE, LLC
    Inventors: Enrich HOFFMAN, Hong Jin, Bin Lu, Greg Duke, George Kemble
  • Patent number: 8722059
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: May 13, 2014
    Assignee: MedImmune, LLC
    Inventors: Erich Hoffman, Hong Jin, Bin Lu, Greg Duke, George Kemble
  • Publication number: 20120020997
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Application
    Filed: August 19, 2011
    Publication date: January 26, 2012
    Inventors: Erich Hoffman, Hong Jin, Bin Lu, Greg Duke, George Kemble
  • Patent number: 8012736
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: September 6, 2011
    Assignee: Medimmune, LLC
    Inventors: Erich Hoffman, Hong Jin, Bin Lu, Greg Duke, George Kemble
  • Publication number: 20040029251
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Application
    Filed: April 25, 2003
    Publication date: February 12, 2004
    Applicant: Medlmmune Vaccines, Inc.
    Inventors: Erich Hoffman, Hong Jin, Bin Lu, Greg Duke, George Kemble